APPROVALS
Australia
Hunter New England Local Health District Human Research Ethics Committee (HREC)
Phone: +61 2 4921 4140
Email: HNELHD-ResearchOffice@health.nsw.gov.au
Ethics: 2024/ETH00569 (19 April 2024)
Trial Registration ID: NCT06771050
The ROADMAP Trial has been reviewed and approved by numerous Human Research Ethics Committees (HRECs) and Regulatory Bodies around the world. Please see the table below for a full list of these approvals in each region.
Hunter New England Local Health District Human Research Ethics Committee (HREC)
Phone: +61 2 4921 4140
Email: HNELHD-ResearchOffice@health.nsw.gov.au
Ethics: 2024/ETH00569 (19 April 2024)
Trial Registration ID: NCT06771050
Mount Sinai Hospital Research Ethics Board
Phone: 416-586-4875
Email: REB.Office@sinaihealth.ca
Ethics: Project ID: 5536 (Approved 26 February 2026)
Northern A Health and Disability Ethics Committee
Email: hdecs@health.govt.nz
Ethics: 2025 FULL 21477 (Approved 16 June 2026)
TBA
ROADMAP is supported by a number of key personnel in a global trial management group (TMG) as well as a global trial steering committee (GTSC), regional trial management groups from each participating country, and ROADMAP specialist working groups. Together they all guide the study to meet its research goals with scientific validity, safety and with a focus on improving health outcomes for people that experience prosthetic joint infections.
